원래 이름 기록: Bio-Rad Laboratories, Inc.

Systems and methods for conducting customized automated crossover studies for clinical diagnostic analyzers are disclosed. In disclosed embodiments, an optimal number of samples to run on a new QC material is determined based on historical information of the analyzer instrument and a peer group of similar instruments. Using the determined optimal number of samples, the crossover study is conducted, and the results are reported.

Systems and methods for performing testing of a single analyte on a group of multiple clinical diagnostic analyzers, or a single clinical diagnostic analyzer having multiple analytic units, or combinations thereof, are disclosed. A mean and SD for each individual instrument are input to at least one of the instruments along with a QC rule to be used, the probability of false rejection function for the QC rule, and a desired false rejection rate. A group mean and a group SD are calculated to satisfy the desired false rejection rate and QC rule and loaded into each individual instrument for use in testing the single analyte at each individual instrument.